Skip to Content
Premium Article

Fidelity Growth Company Stumbles

Biotech, Internet-infrastructure bets turn sour.


A fairly risky profile has taken a toll on Fidelity Growth Company (FDGRX).

Through 2001's first couple of months, this fund has gotten slammed. Although manager Steve Wymer hadn't built a huge tech stake--he'd stashed 31% of assets in the sector as of December 31, 2001--many of his picks haven't fared well this year. The stocks of several of the fund's high-priced Net-infrastructure plays, including Network Appliances (NTAP), Cisco Systems (CSCO), and Sun MicroSystems (SUNW), have gotten punished as their earnings weakened. Wymer's health-care picks, which had boosted returns in 1999 and 2000, have also taken a dive, with drugmaker Sepracor (SEPR) falling especially hard. For the year to date through March 2, 2001, the fund had lost 18%--putting it six percentage points behind its average rival.

This article is exclusive to Morningstar Premium members.

Start a 14-Day Free Trial

Scott Cooley does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.